4//SEC Filing
FREEMAN KEVIN D 4
Accession 0001133416-25-000010
CIK 0001133416other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 4:04 PM ET
Size
5.2 KB
Accession
0001133416-25-000010
Insider Transaction Report
Form 4
FREEMAN KEVIN D
Director
Transactions
- Award
Stock Option (right to buy)
2025-01-23+60,000→ 60,000 totalExercise: $1.23Exp: 2035-01-23→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan.
- [F2]The options vest 100% on December 31, 2025.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeother
Related Parties
1- filerCIK 0001522478
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 4:04 PM ET
- Size
- 5.2 KB